Brokerages Set Kyverna Therapeutics, Inc. (NASDAQ:KYTX) PT at $18.33
Shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) have been assigned an average recommendation of “Buy” from the seven brokerages that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating, five have assigned a buy rating and one has given a strong […]
Shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) have been assigned an average recommendation of “Buy” from the seven brokerages that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating, five have assigned a buy rating and one has given a strong […]
